We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 795

Yeda Research and Development Co., Ltd. v. Mylan Pharmaceuticals Inc. & Teva Pharmaceuticals USA, Inc. v. Sandoz Inc.
  • Knobbe Martens
  • USA
  • October 15 2018

Non-prior art evidence may be considered when evaluating the knowledge, motivations, and expectations of a POSITA regarding the prior art. In addition

Asters defends interests of Teva Pharmaceutical Industries Ltd. before Supreme Court
  • Asters
  • Ukraine
  • October 3 2018

Asters team successfully defended interests of Teva Pharmaceutical Industries Ltd (Teva), one of the world's largest pharmaceutical companies and

High Court invalidates Gilead's SPC for 'TRUVADA' in UK
  • Potter Clarkson LLP
  • United Kingdom, European Union
  • October 2 2018

Hot on the heels of July's judgment from the Court of Justice of the EU (CJEU), Mr Justice Arnold has handed down his final decision in Teva v Gilead

Top SCOTUS Cases that Matter for Tech, Life Sciences and Games Industries - 2018 Term Preview
  • Fenwick & West LLP
  • USA
  • October 1 2018

As the U.S. Supreme Court kicks off its 2018 term this week, it prepares to take up a series of firsts, including questions about the America

The ECJ Clarifies Contested Condition for obtaining an SPC
  • Accura Advokatpartnerselskab
  • United Kingdom, Denmark, European Union
  • August 22 2018

On 25 July 2018, the ECJ delivered its much-anticipated judgment in the case between Teva and Gilead (C 12117) regarding the supplementary protection

SPCs for combination products: a combination of requirements?
  • Potter Clarkson LLP
  • European Union
  • August 2 2018

On 25 July 2018, the Court of Justice of the European Union (CJEU) handed down a judgment in Teva v Gilead (C-12117) concerning Supplementary

Supreme Court to Consider Whether Confidential Sale Triggers On-Sale Bar
  • McDermott Will & Emery
  • USA
  • July 25 2018

The US Supreme Court granted certiorari to consider the question of whether, under the America Invents Act, an inventor's sale of an invention to a

Keeping the foreign parent corporation out of legal trouble
  • Masuda Funai Eifert & Mitchell Ltd
  • USA
  • July 18 2018

A subsidiary of a foreign parent corporation should try to protect the parent from liability under America’s employment laws

  • Masuda Funai Eifert & Mitchell Ltd
  • USA
  • July 18 2018

外国法人を親会社に持つ米国子会社は親会社が米国雇用法による責任を負うことがないように注意すべきである通常の場合親会社と子会社間には共有資産があり取締役の兼任が見られるが親会社と子会社は親会社を保護するための対策を講じ責任を完全に回避できないような状況では子会社だけに責任が生じるようにすべきであるMiddlebrooks対Teva Pharmaceuticals USA, Inc.事件(2018 U.S. Dist. LEXIS 18185 (E.D. Pa. 2018))の判決は教訓的判例と言えよう

High Court to Hear Helsinn v. Teva, Resolve AIA Secret Sales Question
  • Jones Day
  • USA
  • July 9 2018

On June 25, 2018, the United States Supreme Court agreed to review the Federal Circuit's decision in Helsinn Healthcare v. Teva Pharmaceuticals, No